Improvement of Adherence with Occlu-Pad Therapy for Pediatric Patients with Amblyopia

<div>Best-corrected visual acuity (BCVA) for anisometropic amblyopia patients, from baseline to 3, 6, 9, and 12 months. Occlu-pad vs. Patching. BCVA significantly differed between Occlu-pad and Patching at 6, 9, and 12 months (<sup>∗</sup>p=0.02, <sup>∗</sup>p=0.02, <sup>∗</sup>p=0.03; ANOVA).</div>

BioMed Research International

fig2

Figure 2

Figure 2: Improvement of Adherence with Occlu-Pad Therapy for Pediatric Patients with Amblyopia 